Related Experiment Videos
[Diagnosis and therapy of Budd-Chiari syndrome]
R Bachmann1, H Strunk, K A Brensing
1Radiologische und Universitätsklinik Bonn.
Insights
Interventional techniques safely and effectively treat Budd-Chiari syndrome, resolving symptoms. These minimally invasive procedures offer diverse options for managing this rare hepatic outflow obstruction.
Area of Science:
- Interventional Radiology
- Hepatology
- Vascular Surgery
Background:
- Budd-Chiari syndrome, characterized by hepatic venous outflow obstruction, leads to portal hypertension and splanchnic congestion.
- Delayed diagnosis is common in Europe due to the rarity of Budd-Chiari syndrome.
- This study focuses on interventional treatment modalities for Budd-Chiari syndrome.
Observation:
- Three patients with Budd-Chiari syndrome underwent distinct interventional procedures.
- Case 1: Veno-occlusive disease treated with a transjugular intrahepatic portosystemic stent-shunt.
- Case 2: Hepatic vein occlusion treated with percutaneous recanalization and stenting.
- Case 3: Membranous obstruction treated with percutaneous balloon dilatation.
Findings:
- All three patients experienced complete resolution of clinical symptoms post-treatment.
- No complications were reported in any of the treated patients.
- Interventional techniques demonstrated safety and efficacy in managing Budd-Chiari syndrome.
Implications:
- Interventional therapeutic techniques provide a versatile, safe, effective, and cost-efficient approach to Budd-Chiari syndrome management.
- Further research is warranted to evaluate the long-term outcomes and survival rates associated with these interventions.
- Minimally invasive treatments offer promising alternatives for patients with Budd-Chiari syndrome.
Purpose:
Budd-Chiari syndrome is a fairly uncommon disease in Europe. This often leads to its late diagnosis. The syndrome is characterised by portal hypertension and splanchnic congestion due to obstruction of hepatic venous outflow. This paper describes the treatment of three patients with Budd-Chiari syndrome by interventional therapeutic techniques and discusses alternative treatment modalities.
Patients And Methods:
The first patient presented with veno-occlusive disease and was treated by the placement of a transjugular intrahepatic portosystemic stent-shunt. The second patient showed an occlusion of the major hepatic veins. After percutaneous recanalisation, a stent was placed in the right hepatic vein which remained patient. The third patient had a membranous obstruction of the right hepatic vein which was treated by percutaneous balloon dilatation.
Results:
In all patients the clinical symptoms resolved completely after treatment and no complications were encountered.
Conclusions:
The authors conclude that interventional therapeutic techniques offer a wide variety of possibilities for the treatment of patients with Budd-Chiari syndrome and are safe, effective and relatively inexpensive. However, further studies are required to assess the long-term results and survival rates of these patients.